Genetic Factors Linked to Lichen Planus

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on skin and immune health. Browse all Skin & Immune Health education

Lichen planus is a chronic inflammatory condition that can affect the skin, mouth, nails, scalp, and genital tissue. On the skin it often appears as itchy, flat-topped, purplish bumps; in the mouth it can show up as lacy white patches. It is not contagious and not cancerous, but it can be persistent and uncomfortable. Researchers increasingly see it as an immune-driven condition with a genetic component.

What Lichen Planus Is

At its core, lichen planus is a T-cell-mediated reaction in which the immune system targets the basal layer of the skin or mucous membranes. The result is the characteristic inflammation, thinning, and pigment change. It most often appears between ages 30 and 60 and can flare and settle over months or years. Because several everyday triggers overlap with it, pinning down a single cause is often difficult.

The Immune Mechanism Behind the Rash

The lesions form when cytotoxic T lymphocytes accumulate at the dermal-epidermal junction and drive keratinocytes toward programmed cell death. Cytokines such as interferon-gamma and tumor necrosis factor amplify the response. This is why lichen planus is grouped with autoimmune and immune-dysregulation conditions rather than infections — the immune signaling, not a germ, sustains the reaction.

Named Genetic Associations: HLA and Beyond

The strongest genetic links sit in the HLA (human leukocyte antigen) region, which governs how immune cells recognize self versus non-self. Specific alleles including HLA-DRB1 and HLA-DQB1 have been associated with cutaneous and oral lichen planus across several populations. Variants in TNF-alpha (the gene for tumor necrosis factor) and interferon-gamma signaling genes have also been studied for their role in the intensity of the inflammatory response. These associations do not mean a gene "causes" lichen planus; they describe an inherited tendency toward the immune pattern that underlies it.

Triggers and the Hepatitis C Connection

Lichen planus has documented associations with hepatitis C infection, certain medications, dental restorative materials, and stress. The hepatitis C link is one of the most studied and is thought to reflect shared immune activation. Identifying and, where possible, removing a trigger — under medical supervision — is a standard part of evaluation. None of this is a self-treatment plan; it is context for an informed conversation with a clinician.

Working With a Provider on Evidence-Based Care

Because lichen planus can mimic other conditions, diagnosis is clinical and sometimes confirmed by biopsy. Management is individualized and belongs with a qualified provider — often a dermatologist or, for oral disease, a dentist or oral-medicine specialist. Genetic or pathway insight does not replace that evaluation. What it can do is help you understand the immune biology involved so the conversation is better informed.

Where Genetic Insight Fits In

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across immune and inflammatory pathways, among others. It does not diagnose lichen planus, predict flares, or recommend therapy. It offers pathway-level education about your inflammatory and immune-signaling biology — one input among many that you and your provider can consider alongside examination, history, and appropriate testing.

Frequently Asked Questions About Lichen Planus Genetics

Is lichen planus genetic?

Lichen planus is not inherited in a straightforward pattern, but genetics plays a role. Variants in immune-regulating HLA genes such as HLA-DRB1 and HLA-DQB1 are associated with higher susceptibility. These describe an inherited tendency toward the immune reaction, not a guarantee that the condition will develop.

Can genetic testing diagnose lichen planus?

No. Lichen planus is diagnosed clinically by a healthcare provider, sometimes with a skin or mucosal biopsy. Genetic testing does not diagnose it. Pathway-level insight can help you understand the immune biology involved, but it is educational context, not a diagnostic tool or a substitute for medical evaluation.

Is lichen planus contagious?

No, lichen planus is not contagious. You cannot catch it from or pass it to another person through contact. It is an immune-mediated condition, not an infection. Because it is linked with hepatitis C in some cases, a provider may screen for that separately during a full evaluation.

Curious how your own biology reads at the pathway level? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — giving you educational context about the pathways discussed here, not a diagnosis. Genetics is a guide, not a guarantee, and your results are a starting point for a conversation with your provider.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, or prevent any condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Skin & Immune Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.